Total Payments
$5,866
2024 Payments
$4,670
Companies
13
Transactions
24
Medicare Patients
491
Medicare Billing
$62,904
Payment Breakdown by Category
Consulting$4,500 (76.7%)
Food & Beverage$940.73 (16.0%)
Education$424.90 (7.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,500 | 5 | 76.7% |
| Food and Beverage | $940.73 | 14 | 16.0% |
| Education | $424.90 | 5 | 7.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $4,500 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $247.84 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $199.93 | 2 | $0 (2024) |
| Gilead Sciences, Inc. | $134.14 | 3 | $0 (2023) |
| PFIZER INC. | $125.00 | 1 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $117.84 | 1 | $0 (2018) |
| Incyte Corporation | $99.24 | 2 | $0 (2023) |
| Astellas Pharma US Inc | $90.56 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $90.28 | 2 | $0 (2023) |
| Genentech, Inc. | $85.32 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,670 | 7 | Amgen Inc. ($4,500) |
| 2023 | $351.03 | 8 | Gilead Sciences, Inc. ($134.14) |
| 2022 | $99.99 | 1 | AstraZeneca Pharmaceuticals LP ($99.99) |
| 2019 | $143.36 | 2 | E.R. Squibb & Sons, L.L.C. ($129.11) |
| 2018 | $476.32 | 5 | E.R. Squibb & Sons, L.L.C. ($118.73) |
| 2017 | $125.00 | 1 | PFIZER INC. ($125.00) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/28/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 09/18/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 09/18/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| 07/26/2024 | AstraZeneca Pharmaceuticals LP | — | Education | In-kind items and services | $99.94 | General |
| 05/30/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 05/30/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 01/16/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $69.99 | General |
| 12/05/2023 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Oncology | ||||||
| 11/03/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: ONC | ||||||
| 10/10/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.10 | General |
| 09/06/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.05 | General |
| 09/01/2023 | Novartis Pharmaceuticals Corporation | TABRECTA (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Oncology | ||||||
| 03/15/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: ONCOLOGY | ||||||
| 03/09/2023 | Incyte Corporation | — | Education | Cash or cash equivalent | $84.99 | General |
| 01/30/2023 | SANOFI-AVENTIS U.S. LLC | JEVTANA (Drug) | Education | In-kind items and services | $69.99 | General |
| Category: Oncology | ||||||
| 11/30/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $99.99 | General |
| Category: Respiratory | ||||||
| 08/26/2019 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $14.25 | General |
| 02/13/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $129.11 | General |
| 11/20/2018 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar, Xofigo | Food and Beverage | In-kind items and services | $77.37 | General |
| Category: Oncology | ||||||
| 11/12/2018 | Genentech, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $85.32 | General |
| Category: None | ||||||
| 05/16/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $77.06 | General |
| 02/14/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $118.73 | General |
| 01/03/2018 | Janssen Scientific Affairs, LLC | YONDELIS (Drug), ZYTIGA | Food and Beverage | In-kind items and services | $117.84 | General |
| Category: Oncology | ||||||
| 02/01/2017 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $125.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 134 | 196 | $49,000 | $19,892 |
| 2022 | 5 | 139 | 316 | $56,601 | $15,851 |
| 2021 | 3 | 88 | 252 | $32,492 | $10,580 |
| 2020 | 5 | 130 | 373 | $57,741 | $16,581 |
Total Patients
491
Total Services
1,137
Medicare Billing
$62,904
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 51 | 52 | $12,740 | $5,628 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 52 | $14,300 | $5,391 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 64 | $12,160 | $4,881 | 40.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 17 | $5,950 | $2,564 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,850 | $1,429 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 65 | 200 | $36,247 | $10,311 | 28.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $3,677 | $1,573 | 42.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 23 | 47 | $6,343 | $1,430 | 22.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $5,587 | $1,306 | 23.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 26 | 44 | $4,747 | $1,231 | 25.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 45 | 157 | $21,352 | $7,787 | 36.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 27 | 72 | $9,576 | $2,196 | 22.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 16 | 23 | $1,564 | $597.39 | 38.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 58 | 263 | $35,768 | $10,499 | 29.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 22 | 38 | $9,343 | $2,225 | 23.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 13 | 13 | $5,798 | $1,780 | 30.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 14 | 20 | $4,180 | $1,281 | 30.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 23 | 39 | $2,652 | $795.86 | 30.0% |
About Dr. Diane Hershock, MD
Dr. Diane Hershock, MD is a Hematology healthcare provider based in Easton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770652158.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Diane Hershock, MD has received a total of $5,866 in payments from pharmaceutical and medical device companies, with $4,670 received in 2024. These payments were reported across 24 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($4,500).
As a Medicare-enrolled provider, Hershock has provided services to 491 Medicare beneficiaries, totaling 1,137 services with total Medicare billing of $62,904. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Medical Oncology, Hematology & Oncology
- Location Easton, PA
- Active Since 11/07/2006
- Last Updated 01/20/2026
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1770652158
Products in Payments
- YONDELIS (Drug) $117.84
- FASENRA (Biological) $99.99
- Trodelvy (Drug) $99.99
- Non-Covered Product (Drug) $85.32
- Stivarga (Drug) $77.37
- JEVTANA (Drug) $69.99
- Enhertu (Drug) $28.12
- Xospata (Drug) $20.57
- TABRECTA (Drug) $13.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.